Please try another search
Hoechst Pakistan Limited engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally. The company provides its antibiotic, cardiology, diabetes, pain and allergy, and other products under Flagyl, Clexane, NO-SPA, Lantus, Amaryl, Claforan, Haemaccel, Enterogermina, and Plavix brands. It also offers various shampoos under the Selsun Blue brand name. The company was formerly known as Sanofi-Aventis Pakistan Limited and changed its name to Hoechst Pakistan Limited in September 2023. Hoechst Pakistan Limited was incorporated in 1967 and is headquartered in Karachi, Pakistan.
Name | Age | Since | Title |
---|---|---|---|
Imtiaz Ahmed Husain Laliwala | - | 2017 | Independent Director |
Syed Hyder Ali | - | 1987 | Non-Executive Director |
Arshad Ali Gohar | - | 2011 | Non-Executive Director |
Syed Babar Ali | - | 1977 | Non-Executive Chairman |
Iqra Sajjad | - | 2023 | Non-Executive Director |
Syed Anis Ahmad Shah | - | 2023 | Independent Director |
Muhammad Salman Burney | - | 2023 | Non-Executive Director |
Sajjad Iftikhar | - | 2023 | CEO & Executive Director |
Saadia Butt Naveed | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review